0001600132-18-000179.txt : 20181123
0001600132-18-000179.hdr.sgml : 20181123
20181123162438
ACCESSION NUMBER: 0001600132-18-000179
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181120
FILED AS OF DATE: 20181123
DATE AS OF CHANGE: 20181123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tenenbaum Fabian
CENTRAL INDEX KEY: 0001641300
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 181199730
MAIL ADDRESS:
STREET 1: 60 EAST 42ND STREET, SUITE 1160
CITY: NEW YORK
STATE: NY
ZIP: 10165
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
4
1
wf-form4_154300826116009.xml
FORM 4
X0306
4
2018-11-20
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001641300
Tenenbaum Fabian
184 LIBERTY CORNER ROAD
SUITE 302
WARREN
NJ
07059
0
1
0
0
Chief Executive Officer
Stock Option (right to buy)
0.91
2018-11-20
4
A
0
1487500
0
A
2028-11-20
Common Stock
1487500.0
3676197
D
This option was granted on November 20, 2018. This option vests in quarterly installments over a four-years period from the date of grant.
/s/ Fabian Tenenbaum
2018-11-20